How Is Catel-Manzke Syndrome Diagnosed? From Clinical Clues To Genetic Testing
Published on: August 19, 2025
How Is Catel-Manzke Syndrome Diagnosed featured image
Article author photo

Christina Hadera

Bachelor's degree, Biomedical Sciences, General, Brunel University of London

Article reviewer photo

Chandana Raccha

MSc in Pharmacology and Drug Discovery, Coventry University

If you're seeking specifics on how Catel-Manzke syndrome is diagnosed—from early clinical signs to definitive genetic testing—you've come to the right spot. Here is a step-by-step guide to what you (or someone you care about) can anticipate while seeking a diagnosis for this rare condition, based on information rooted in peer-reviewed research and established clinical guidelines.

How Is Catel-Manzke Syndrome Diagnosed? 

Catel-Manzke syndrome is diagnosed via a combination of:

  • X-rays and other imaging studies are used to confirm skeletal abnormalities in the fingers
  • A thorough physical examination for the presence of Pierre Robin sequence symptoms, such as a small lower jaw (micrognathia), cleft palate, and glossoptosis, at or shortly after birth, as well as characteristic traits like bent (clinodactyly) or radially deviated index fingers
  • The condition can be conclusively confirmed through genetic testing, which identifies mutations in the TGDS gene (or, less frequently, BPNT2)1,2,3

Read on

There is still more to learn about Catel-Manzke syndrome, what characteristics doctors look for, how genetic testing works, and the next practical steps. Continue reading for a comprehensive yet understandable review, practical advice, and answers to commonly asked questions about Catel-Manzke syndrome diagnosis.

What Is Catel-Manzke Syndrome?

Unique hand and facial traits are the hallmarks of Catel-Manzke syndrome, a rare genetic disorder that is inherited in an autosomal recessive manner. Usually, the syndrome includes:

  • Hyperphalangy and clinodactyly are abnormal side deviations and bending of the index fingers caused by an extra bone
  • The three hallmarks of the Pierre Robin sequence are glossoptosis (downward displacement of the tongue), cleft palate, and micrognathia (small lower jaw)
  • Growth or developmental delays, unique facial structure, and occasionally skeletal or cardiac abnormalities are additional potential findings2,4,3

Clinical Clues: The First Signs

Early Detection

  • Symptoms frequently develop before delivery or even earlier, and can be detected in some circumstances using a prenatal ultrasound5,2
  • Classic clues are:
    • Bilateral (both sides) bent index fingers, sometimes characterised as "locked" in a flexed position
    • Pierre Robin sequence traits include a small jaw, cleft palate, and difficulty feeding brought on by airway or tongue position
    • Abnormalities can also be discovered during a standard newborn examination or when parents observe feeding and breathing problems shortly after birth6,7

Physical and Medical Examination

  • A geneticist or paediatrician evaluates:
    • Position of the hand and fingers (noting deviated or bending index fingers)
    • Oral and facial characteristics: A smaller lower jaw than expected, cleft palate, and glossoptosis
    • Family history, because the condition is autosomal recessive.
    • Related characteristics include short height, other skeletal abnormalities, or heart murmurs (which could be a sign of heart defects)
  • Differential diagnosis: Physicians must rule out other syndromes that share characteristics, like Desbuquois syndrome or Temtamy preaxial brachydactyly syndrome2

Imaging

  • Hand X-rays can reveal:
    • The index fingers' radial deviation and an additional bone (accessory ossification centre)
    • Metacarpophalangeal joint abnormalities
    • Occasionally, additional minor or uncommon skeletal abnormalities8
  • Additional imaging:
    • If congenital heart abnormalities are suspected, echocardiography may be performed.
    • Skeletal surveys in the event of additional abnormalities

Specialist Referrals

  • Infants may be referred to:
    • Orthopaedic specialists (for digital anomalies)
    • Craniofacial teams (for managing cleft palates)
    • Cardiologists (should any heart abnormalities be discovered)
    • Genetic counsellors for additional assessment and guidance on family planning

The role of genetic testing

Genetic Testing Is the Gold Standard

  • When physical results and X-rays indicate the presence of Catel-Manzke syndrome, molecular genetic testing is carried out
  • This entails analysing DNA, typically from a blood sample, to check for TGDS gene mutations3
  • In rare, related disorders, BPNT2 abnormalities can occasionally be detected9

How Is Genetic Testing Done?

  • Anyone with characteristic clinical signs or a family member with the condition should get tested. If features are seen on ultrasound and there are a known familial risk, it can also be offered during pregnancy
  • A DNA sample is sent to a specialised laboratory as part of the procedure. Using sequencing techniques, researchers look for known pathogenic mutations in the TGDS gene3
  • At-risk parents or siblings may be eligible for carrier testing, and if the familial mutation is identified, prenatal diagnosis may be taken into consideration in subsequent pregnancies

Interpretation and Follow-Up

  • A positive genetic result helps guide future care, confirms the diagnosis, and informs the prognosis
  • Expanding testing panels and considering alternate diagnoses, such as overlapping skeletal dysplasias, are options if the test is negative but clinical suspicion is high
  • Accurate genetic counselling regarding recurrence risk for families is also made possible by genetic testing2,3

Key clinical features to watch for

FeatureDescriptionDiagnostic Value
Bilateral clinodactylyBoth index fingers bent and deviated (radially)Critical—hallmark sign
Pierre Robin sequenceMicrognathia, glossoptosis, cleft palateCritical—core feature
Accessory bone on X-rayExtra ossification centre in the index finger jointsConfirms clinical sign
Developmental delay (sometimes)May be present; varies from mild to severeSupportive
Congenital heart defects (sometimes)E.g. septal defects; less commonSupportive
Distinctive facial featuresWidely spaced eyes, full cheeks, low-set ears, etc.Supportive

Why genetic diagnosis matters

  • Definitive Answer: Eliminates any uncertainty by confirming the clinical diagnosis
  • Guides Management: Specific needs are identified, including airway, feeding, orthopaedic, and speech support
  • Family Planning: Identifies the risk of recurrence and provides information for future pregnancies
  • Access to Support: Makes it possible to access support groups, education, and specialised services

A step-by-step diagnostic journey

  • Abnormal hand or facial traits or early symptoms are observed, frequently at birth
  • The classical traits are highlighted in paediatric assessment
  • Hand X-rays validate distinct digital findings.
  • Mutations in TGDS (and infrequently BPNT2) are found by genetic testing
  • various referrals based on various characteristics (e.g., for feeding, speech, heart)
  • Genetic counselling is started for family members

Living with the diagnosis

Although the diagnosis may seem overwhelming, understanding the exact cause enables physicians and families to:

  • Organise interdisciplinary treatment that includes genetics, paediatrics, orthopaedics, ENT, speech, and more
  • Keep an eye out for any possible concerns, like trouble feeding or breathing
  • When necessary, schedule support therapy or corrective operations (such as palate repair)

FAQ’s (Frequently Asked Questions)

Can Catel-Manzke syndrome be picked up before birth?

In families where a mutation is known, a prenatal ultrasound may be able to identify specific traits. However, postnatal genetic testing is typically necessary to provide a definitive diagnosis.5,2

Is genetic testing always needed?

For family planning and a conclusive diagnosis, genetic testing is strongly advised. Only TGDS (or BPNT2) molecular analysis can confirm the illness, even though clinical signs may be suggestive.3

Does every affected child have all the main features?

No, expression and severity differ. While not all children may exhibit every symptom, Pierre Robin sequence traits and crooked index fingers are consistently observed.1,2

What other conditions look like Catel-Manzke syndrome?

The significance of genetic confirmation is underscored by the fact that other syndromes with hand abnormalities and facial features (Desbuquois syndrome, Temtamy preaxial brachydactyly syndrome, and brachydactyly type C) may initially appear similar.2

What happens after diagnosis?

It takes an interdisciplinary approach. In addition to regular developmental monitoring and genetic counselling, management concentrates on skeletal, feeding, and respiratory problems.

Summary

A number of distinguishing clinical characteristics must be identified in order to diagnose Catel-Manzke syndrome, chief among them being deviated and bent index fingers as well as the characteristic facial and airway findings of the Pierre Robin sequence. Only genetic testing for mutations in the TGDS gene can yield a definitive diagnosis, while imaging tests confirm clinical suspicion.3 The procedure places a strong emphasis on both emotional comfort and medical clarity: a correct diagnosis leads to individualised treatment and well-informed family planning. See your healthcare practitioner or a genetics specialist if you have any suspicions about a diagnosis or if your traits match those listed below. Treatment and support can be significantly improved by a prompt diagnosis.

References

  1. Boschann, Felix, et al. ‘TGDS Pathogenic Variants Cause Catel‐Manzke Syndrome without Hyperphalangy’. American Journal of Medical Genetics Part A, vol. 182, no. 3, Mar. 2020, pp. 431–36. DOI.org (Crossref), Available from: https://doi.org/10.1002/ajmg.a.61419.
  2. Catel Manzke Syndrome - Symptoms, Causes, Treatment | NORD. Available from: https://rarediseases.org/rare-diseases/catel-manzke-syndrome/. 
  3. ‘Catel-Manzke Syndrome (CATMANS)’. FDNATM, Available from: https://fdna.com/health/resource-center/catel-manzke-syndrome-catmans/. 
  4. Ehmke, Nadja, et al. ‘Homozygous and Compound-Heterozygous Mutations in TGDS Cause Catel-Manzke Syndrome’. The American Journal of Human Genetics, vol. 95, no. 6, Dec. 2014, pp. 763–70. ScienceDirect, Available from: https://doi.org/10.1016/j.ajhg.2014.11.004.
  5. L, Bernd, et al. ‘[Catel-Manzke Syndrome]’. Klinische Padiatrie, vol. 202, no. 1, Feb. 1990. pubmed.ncbi.nlm.nih.gov, Available from: https://doi.org/10.1055/s-2007-1025488.
  6. Manzke, Hermann, et al. ‘Catel–Manzke Syndrome: Two New Patients and a Critical Review of the Literature’. European Journal of Medical Genetics, vol. 51, no. 5, Sep. 2008, pp. 452–65. ScienceDirect, Available from: https://doi.org/10.1016/j.ejmg.2008.03.005.
  7. Orphanet: Catel-Manzke Syndrome. Available from: http://www.orpha.net/en/disease/detail/1388. 
  8. Pferdehirt, Rachel, et al. ‘Catel–Manzke Syndrome: Further Delineation of the Phenotype Associated with Pathogenic Variants in TGDS’. Molecular Genetics and Metabolism Reports, vol. 4, Aug. 2015, p. 89. pmc.ncbi.nlm.nih.gov, Available from: https://doi.org/10.1016/j.ymgmr.2015.08.003.
  9. R, Pferdehirt, et al. ‘Catel-Manzke Syndrome: Further Delineation of the Phenotype Associated with Pathogenic Variants in TGDS’. Molecular Genetics and Metabolism Reports, vol. 4, Sep. 2015. pubmed.ncbi.nlm.nih.gov, Available from: https://doi.org/10.1016/j.ymgmr.2015.08.003.
Share

Christina Hadera

Bachelor's degree, Biomedical Sciences, General, Brunel University of London

arrow-right